
Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients
Anteris Technologies announced favorable 30-day clinical outcomes for its Medium-size DurAVR Transcatheter Heart Valve (THV) in 22 patients with severe aortic stenosis. The valve showed excellent hemodynamics with low pressure gradients, large effect...





